No precise dose adjustment advisable when tofacitinib coadministered with potent CYP2C19 inhibitors; minimize tofacitinib dose if coadministered with both moderate CYP3A4 and strong CYP2C19 inhibitors . To view formulary data to start with make a listing of programs. Your listing might be saved a